STORM in the News
Drug Discovery World: Beyond immunotherapy: Could RNA modifying enzymes boost response rates?
Cancer immunotherapy has set new standards in cancer care, but many patients are still not responding. RNA modifying enzymes (RME) research could be a way to improve results. Drug Discovery World’s Megan Thomas reflects on STORM Therapeutics’ approach for the future of this mechanism of action.
Read more